Add to Favorites

License In/Out Service

Both international and local pharmaceutical and medical device company in China have marked the continuously recorded growth with double digits. However with the current trends of increasing local and foreign competition, coming expirations of best selling products, rare approvable of new molecules, cost-saving by outsourcing research and development, access to innovative technology and low productivity/ROI of sale force through a non-synergy product portfolio which created the demand for licensing- in/acquisition of innovative and generic products.


Loudon with local networks of 16 years experience provide Licensing-in/out services for pharmaceutical and medical device company as following:


Portfolio strategy and licensing product opportunities screening
Ad hoc licensing-in product opportunities
New product assessment and business case build up
Introduction and assistance in closing licensing deals
Due diligence: licenser/R & D partners
China market entry strategy for R & D companies: R & D, commercials and legal

Loudon China has established following licensing assets for distribution negotiation in China,


TA Categories
Antiallergic Medicine
Anti-infection Medicine
Obesity Medicine
Respiratory Medicine
Cardiovascular Medicine
Endocrinology Medicine
Gastrointestinal Medicine
Psychiatric Medicine
Neurology Medicine
Pediatrics Medical Device

Here is the detail list of imported products open for further licensing discussions.


Please fill the application form if you are interested of discussing the above products for licensing in Great China


Any questions, pls contact us through Jenny.zhu@loudon-research.com.



abbvie

Actelion

AGFA

astellas

AZ


B+L

Baxter

Bayer

BCG

BD

BI


BMS


Cephalon

Cocacola

COVIDIEN

中信国健

Credit Suisse

EBEWE

Eisai

GSK

Heineken


HELSINN


IPSEN

JJMC

凯利泰

Kowa

Bago

Lilly
McKinsey

Medtronic

MSD

Novartis

Novo nordisk

Optimer

Pfizer

ProMexico

Roche


Sandoz


Sanofi

中美史克
Sumitomo
Takeda


Techpool


Warburg pincus


XJP